Advertisement
Screener

Beyond Air, Inc. (XAIR) Increase (Decrease) in Receivables

2.8 / 5 stars · 68/120 Roast Me

Beyond Air, Inc. Increase (Decrease) in Receivables

Beyond Air, Inc. (XAIR) reported Increase (Decrease) in Receivables of $98.00 thousand for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-22.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInReceivables · last filed 2023-06-22

  • Beyond Air, Inc. increase (decrease) in receivables for the quarter ending 2023-03-31 was $65.00K, a 50.00% decline year-over-year.
  • Beyond Air, Inc. increase (decrease) in receivables for the quarter ending 2022-12-31 was $120.00K, a 37.50% decline year-over-year.
  • Beyond Air, Inc. increase (decrease) in receivables for the quarter ending 2022-09-30 was -$244.00K.
  • Beyond Air, Inc. increase (decrease) in receivables for the quarter ending 2022-06-30 was $157.00K.
  • Beyond Air, Inc. increase (decrease) in receivables for fiscal 2023 was $98.00K.
  • Beyond Air, Inc. increase (decrease) in receivables for fiscal 2022 was -$103.00K, a 124.24% decline from fiscal 2021.
  • Beyond Air, Inc. increase (decrease) in receivables for fiscal 2021 was $425.00K.
Period endIncrease (Decrease) in Receivables 3 monthIncrease (Decrease) in Receivables 6 monthIncrease (Decrease) in Receivables 9 monthIncrease (Decrease) in Receivables 12 month
2023-03-31$65.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22
$185.00K
derived: sum of 2 quarters · filed 2023-06-22
-$59.00K
derived: sum of 3 quarters · filed 2023-06-22
$98.00K
10-K · filed 2023-06-22
2022-12-31$120.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-10
-$124.00K
derived: sum of 2 quarters · filed 2023-02-10
$33.00K
10-Q · filed 2023-02-10
$163.00K
derived: sum of 4 quarters · filed 2023-06-22
2022-09-30-$244.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-08
-$87.00K
10-Q · filed 2022-11-08
$43.00K
derived: sum of 3 quarters · filed 2023-06-22
$235.00K
derived: sum of 4 quarters · filed 2023-06-22
2022-06-30$157.00K
10-Q · filed 2022-08-11
$287.00K
derived: sum of 2 quarters · filed 2023-06-22
$479.00K
derived: sum of 3 quarters · filed 2023-06-22
$479.00K
derived: sum of 4 quarters · filed 2023-06-22
2022-03-31$130.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22
$322.00K
derived: sum of 2 quarters · filed 2023-06-22
$322.00K
derived: sum of 3 quarters · filed 2023-06-22
-$103.00K
10-K · filed 2023-06-22
2021-12-31$192.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-10
$192.00K
derived: sum of 2 quarters · filed 2023-02-10
-$233.00K
10-Q · filed 2023-02-10
2021-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-08
-$425.00K
10-Q · filed 2022-11-08
2021-06-30-$425.00K
10-Q · filed 2022-08-11
2021-03-31$425.00K
10-K · filed 2022-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B